---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-288347"
form_type: "8-K"
ticker: "IVVD"
cik: "0001832038"
company_name: "Invivyd, Inc."
filed_at: "2025-11-19T23:59:59+00:00"
generated_at: "2026-05-16T18:32:41.304969+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Invivyd prices $125M stock and warrant offering; net proceeds ~$117.2M for pipeline funding

## Summary
- Priced 44M shares at $2.50 and 6M pre-funded warrants at $2.4999; gross $125M, net ~$117.2M.
- Offering closed Nov 19, 2025; underwriters have 30-day option for 7.5M additional shares.
- Proceeds for VYD2311 commercial prep, RSV/measles R&D, SPEAR Long COVID study, and working capital.
- Cantor Fitzgerald sole book-runner; H.C. Wainwright lead manager.

## SEC filing metadata
- accession: 0001193125-25-288347
- form_type: 8-K
- ticker: IVVD
- cik: 0001832038
- company_name: Invivyd, Inc.
- filed_at: 2025-11-19T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1832038/000119312525288347/0001193125-25-288347-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1832038/000119312525288347/ivvd-20251117.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-288347
- JSON: https://secwatch.observer/filing/0001193125-25-288347.json
- Plain text: https://secwatch.observer/filing/0001193125-25-288347.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.